Cargando…
Biological Characterization and Therapeutics for Subscalp Recurrent in Intracranial Glioblastoma
PURPOSE: Gliomas are common intracranial tumors, of which 70% are malignant gliomas. Glioblastoma multiforme (GBM) is the most aggressive tumor, and patients with GBM have a median survival time of only 9–12 months; extracranial recurrence of GBM is very rare. A therapeutic strategy for this kind of...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498653/ https://www.ncbi.nlm.nih.gov/pubmed/32982297 http://dx.doi.org/10.2147/OTT.S265322 |